These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18487852)

  • 1. Iron withholding: a defense against disease.
    Weinberg ED; Miklossy J
    J Alzheimers Dis; 2008 May; 13(4):451-63. PubMed ID: 18487852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iron: the Redox-active center of oxidative stress in Alzheimer disease.
    Castellani RJ; Moreira PI; Liu G; Dobson J; Perry G; Smith MA; Zhu X
    Neurochem Res; 2007 Oct; 32(10):1640-5. PubMed ID: 17508283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of iron as a mediator of oxidative stress in Alzheimer disease.
    Castellani RJ; Moreira PI; Perry G; Zhu X
    Biofactors; 2012; 38(2):133-8. PubMed ID: 22447715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches.
    Kontoghiorghes GJ; Weinberg ED
    Blood Rev; 1995 Mar; 9(1):33-45. PubMed ID: 7795423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron loading and disease surveillance.
    Weinberg ED
    Emerg Infect Dis; 1999; 5(3):346-52. PubMed ID: 10341171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron withholding: a defense against viral infections.
    Weinberg ED
    Biometals; 1996 Oct; 9(4):393-9. PubMed ID: 8837461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species.
    Casadesus G; Smith MA; Zhu X; Aliev G; Cash AD; Honda K; Petersen RB; Perry G
    J Alzheimers Dis; 2004 Apr; 6(2):165-9. PubMed ID: 15096700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metals in neurodegenerative diseases.
    Sayre LM; Perry G; Atwood CS; Smith MA
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):731-41. PubMed ID: 10875436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress and neurodegeneration: the involvement of iron.
    Carocci A; Catalano A; Sinicropi MS; Genchi G
    Biometals; 2018 Oct; 31(5):715-735. PubMed ID: 30014355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron: a pathological mediator of Alzheimer disease?
    Bishop GM; Robinson SR; Liu Q; Perry G; Atwood CS; Smith MA
    Dev Neurosci; 2002; 24(2-3):184-7. PubMed ID: 12401957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease.
    Castellani RJ; Honda K; Zhu X; Cash AD; Nunomura A; Perry G; Smith MA
    Ageing Res Rev; 2004 Jul; 3(3):319-26. PubMed ID: 15231239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hazards of iron loading.
    Weinberg ED
    Metallomics; 2010 Nov; 2(11):732-40. PubMed ID: 21072364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transition metals copper and iron in neurodegenerative diseases.
    Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
    Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron loading: a risk factor for osteoporosis.
    Weinberg ED
    Biometals; 2006 Dec; 19(6):633-5. PubMed ID: 16648989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of iron chelation in free radical-induced oxidative stress and human disease.
    Jomova K; Valko M
    Curr Pharm Des; 2011; 17(31):3460-73. PubMed ID: 21902663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress mechanisms and potential therapeutics in Alzheimer disease.
    Moreira PI; Siedlak SL; Aliev G; Zhu X; Cash AD; Smith MA; Perry G
    J Neural Transm (Vienna); 2005 Jul; 112(7):921-32. PubMed ID: 15583960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
    Perry G; Sayre LM; Atwood CS; Castellani RJ; Cash AD; Rottkamp CA; Smith MA
    CNS Drugs; 2002; 16(5):339-52. PubMed ID: 11994023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress, antioxidants, and Alzheimer disease.
    Rottkamp CA; Nunomura A; Raina AK; Sayre LM; Perry G; Smith MA
    Alzheimer Dis Assoc Disord; 2000; 14 Suppl 1():S62-6. PubMed ID: 10850732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of iron chelators in diseases associated with iron mismanagement.
    Weinberg ED
    J Pharm Pharmacol; 2006 May; 58(5):575-84. PubMed ID: 16640825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.